STOCK TITAN

Concentrix Corp (CNXC) SEC Filings, Jun-Sep 2025

CNXC NASDAQ
Rhea-AI Summary

Form 144 notice for Concentrix Corp (CNXC) reports a proposed sale of 500 restricted shares by the named person through Morgan Stanley Smith Barney, with an aggregate market value of $23,540 and an approximate sale date of 09/30/2025 on NASDAQ. The shares were originally acquired as restricted stock on 06/01/2021 from the issuer. The filer also reported two recent sales by the same person in the past three months: 500 shares sold on 07/30/2025 for $28,955 and 500 shares sold on 08/29/2025 for $25,125. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Concentrix Corporation filed a current report stating that it has released its financial results for the third quarter ended August 31, 2025. The company issued a press release on September 25, 2025 to share details about its operations and financial condition for the period.

The press release is included as an exhibit to the report and is incorporated by reference into the results section, giving investors and analysts a central source for the company’s latest quarterly performance information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.33%
Tags
current report
-
Rhea-AI Summary

Concentrix Corp (CNXC) reporting person Cormac J. Twomey, EVP Global Ops & Delivery, reported a sale of 500 shares of Common Stock on 08/29/2025 at a price of $50.25 per share. After the sale, the reporting person beneficially owned 36,630 shares. The filing states the sale was executed pursuant to a Rule 10b5-1 trading plan established on January 28, 2025.

The Form 4 is signed by an attorney-in-fact and indicates this was a planned disposition rather than an ad hoc trade. No derivative transactions or other changes in holdings are reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Form 144 notice shows a proposed insider sale of 500 common shares scheduled for 08/29/2025 through Morgan Stanley Smith Barney LLC, with an aggregate market value of $25,125. The shares were originally acquired as restricted stock on 06/01/2021 from the issuer. The filing reports total shares outstanding of 63,025,120, and lists three recent sales by the same seller of 500 shares each on 05/30/2025, 06/30/2025 and 07/30/2025 with gross proceeds shown. The seller is named as Cormac Twomey with an address provided. The filing includes the standard representation that the seller is unaware of undisclosed material adverse information.

Note: The issuer name and SEC file number are not provided in the supplied content.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

AQR Capital Management, LLC and its parent AQR Capital Management Holdings, LLC report shared beneficial ownership of 4,305,469 shares of Concentrix common stock, representing 6.83% of the class. Both entities disclose shared voting and shared dispositive power over these shares and report no sole voting or sole dispositive power.

The filing states the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer. AQR Capital Management, LLC is identified as a wholly owned subsidiary of AQR Capital Management Holdings, LLC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.04%
Tags
other
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.21%
Tags
other

FAQ

How many Concentrix (CNXC) SEC filings are available on StockTitan?

StockTitan tracks 91 SEC filings for Concentrix (CNXC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Concentrix (CNXC)?

The most recent SEC filing for Concentrix (CNXC) was filed on September 30, 2025.